1. Home
  2. TCBK vs NVCR Comparison

TCBK vs NVCR Comparison

Compare TCBK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$58.20

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.26

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
NVCR
Founded
1975
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
TCBK
NVCR
Price
$58.20
$15.26
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$54.60
$28.08
AVG Volume (30 Days)
579.3K
1.9M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
2.87%
N/A
EPS Growth
6.94
21.79
EPS
1.04
N/A
Revenue
$53,445,000.00
$655,353,000.00
Revenue This Year
$12.03
$7.72
Revenue Next Year
$4.47
$6.74
P/E Ratio
$55.81
N/A
Revenue Growth
4.12
8.28
52 Week Low
$39.84
$9.82
52 Week High
$61.71
$21.45

Technical Indicators

Market Signals
Indicator
TCBK
NVCR
Relative Strength Index (RSI) 56.91 44.10
Support Level $48.57 $14.85
Resistance Level $61.71 $15.46
Average True Range (ATR) 1.39 1.19
MACD -0.28 -0.05
Stochastic Oscillator 57.33 1.26

Price Performance

Historical Comparison
TCBK
NVCR

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: